Enhancing Drug Development Through Comprehensive Models and Advanced Technologies

This chapter delves into the importance of complete models for studying immune cell targeting in tumors, emphasizing the need for including various components like tumor cells, fibroblasts, and blood vessels. It highlights how comprehensive models have influenced drug development decisions, showcasing successful advancements towards clinical trials and the impact on treatment responses. The chapter also explores the potential of organ-on-a-chip technology in transforming drug discovery processes and the balance between using animal models and in vitro models for predictive capabilities.